Sick Company is there to connect struggling companies with investors looking for opportunity. It specializes in helping those in need of capital infusion by matching them with those with funds. This means securing investment via equity funding is a matter of finding those willing to invest money in startups in exchange for equity in the company. Such a process is about identifying opportunities for growth.

Sick Company also provides guidance to young companies–like mentorship and access to sales networks. This involves financial projections: future capital requirements, revenue and profit, and an ROI timeline must be spelled out.

Keep in mind that conventional Fintech is only for short-term loan packages. They provide short-term, high-interest business loans for entrepreneurs looking to quickly grow and expand with capital. This requires flexibility, which makes alternative lenders the most viable option for some businesses that are merely looking for working capital to get through difficult times. So conventional Fintech lenders can be a great funding option for small business owners. The downside to many alternative lenders, though, is the tendency to charge high interest rates and offer demanding loan agreements. But struggling businesses don’t always have access to the capital / collateral to cover these short-term loans. Sick Company doesn’t have such drawbacks. It is a revolutionary approach for shoring up faltering businesses, which applies an open-source model to age-old problems.